MSF calls on Global Fund Board to make urgent changes to prevent drug stock-outs and quality issues Geneva – On the eve of the Board meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) called on the Board to make urgent changes to … Read more
The Hague — Activists interrupted the opening ceremony of the 49th Union World Conference on Lung Health in The Hague today, to call on US pharmaceutical corporation Johnson & Johnson (J&J) to cut the price of the TB drug bedaquiline in half, to ‘one dollar per day’, so that people who urgently need it can afford … Read more
We call on US pharma corporation Johnson & Johnson to cut key TB drug price in half The Hague — People with drug-resistant tuberculosis (DR-TB) continue to be deprived of today’s best-possible treatment in part because of high drug prices, according to a new report — DR-TB Drugs Under the Microscope — released today by … Read more
Sharonann Lynch, HIV & TB advisor for Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, made the following statement today following the first-ever United Nations High-Level Meeting on Tuberculosis (TB): “The good news is this historic meeting happened at a time when the world is equipped with new, more effective medicines and diagnostics to fight … Read more
Urgent need to scale up newer tools available today to save lives; and develop a fast, safe and simple cure for TB New York — As global leaders gather for the first-ever United Nations tuberculosis (TB) Summit in New York this week, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) called on … Read more
Gilead’s price gouging for Sofosbuvir blocks millions of people from getting treatment Munich/Paris/New York – This week in Munich, the European Patent Office is hearing a legal challenge filed by groups in 17 countries in March 2017 against an unmerited patent that allows US pharmaceutical corporation Gilead Sciences to charge exorbitant prices in Europe for the … Read more
MSF calls on Johnson & Johnson to make key drug bedaquiline affordable for all people who need it Geneva — The international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) today welcomed the new World Health Organization (WHO) recommendations for improved treatment for people with drug-resistant tuberculosis (DR-TB), prioritising the use of several oral drugs, … Read more
US government exerting extreme pressure, threatening not to endorse declaration New York – Countries negotiating the final declaration text for the first-ever UN High-level Meeting on Tuberculosis in September are being put under significant pressure to drop all references to protecting countries’ rights to take fully-legal actions to access affordable medicines for their people, Doctors … Read more
RCEP trade deal could cut medicines lifeline for people in developing countries Bangkok/Geneva – As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed-door negotiations, public health experts and the international medical humanitarian organization – Doctors Without Borders/Médecins Sans Frontières (MSF) warn that the … Read more
Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes two patent oppositions filed by Delhi Network of Positive People (DNP+) before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir. These oppositions challenge Gilead’s patent applications for the tablet formulation of the fixed-dose combination of … Read more